Supplemental material
Open access
3,625
Views
37
CrossRef citations to date
0
Altmetric
Original Article
Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial
Denis KeohanePfizer Inc., New York, NY, USA; Correspondence[email protected]
View further author information
, View further author information
Jeffrey SchwartzPfizer Inc., New York, NY, USA; View further author information
, Balarama GundapaneniinVentiv Health Inc., Burlington, MA, USAView further author information
, Michelle StewartPfizer Inc., New York, NY, USA; View further author information
& Leslie AmassPfizer Inc., New York, NY, USA; View further author information
Pages 30-36
|
Received 06 Jun 2016, Accepted 27 Feb 2017, Published online: 10 Apr 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.